SSRIs vs SNRIs: Efficacy Compared for Pediatric Anxiety Disorders

By March 19, 2018

The authors noted that treatment with SSRIs led to significantly greater improvement by the second week of treatment vs. SNRIs (P=0.0268); this benefit remained statistically significant through Week 12.

Are Psychiatric Drugs Being Overprescribed in Children and Adolescents?

By January 30, 2018

"Our results show that, at a population level, prescriptions of stimulants and antidepressant medications for children and adolescents do not appear to be prescribed at rates higher than the known rates for psychiatric conditions they are designed to treat," said the study's lead author, Dr. Ryan Sultan.

Recall: Defective Droppers Packaged with Anti-Anxiety Drug

By August 15, 2017

The dosing droppers, supplied by a third party, were misprinted with the dose markings in reverse number, shifted dose markings or no dose markings.

Do Pre-Existing Psychiatric Conditions Impact Opioid Use?

By December 29, 2016

Study authors reported evidence of greater opioid receipt among commercially insured patients with a wide range of psychiatric conditions.

PTSD Drug Candidate Granted Breakthrough Therapy Designation

By December 19, 2016

Tonix announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TNX-102 SL (cyclobenzaprine HCl sublingual tablets) for the treatment of posttraumatic stress disorder (PTSD).

Adverse Drug Events via Breastfeeding: Commonly Reported Medications

September 05, 2014

Adverse drug events in children due to the ingestion of drugs excreted in breast milk are poorly reported but potentially dangerous.

Cancer Patients Need Anxiety, Depression Screening

April 22, 2014

It is important to recognize and treat anxiety or depression among cancer patients, according to panel recommendations.